Vertex Pharmaceuticals Ownership | Who Owns Vertex Pharmaceuticals?
Vertex Pharmaceuticals Ownership Summary
Vertex Pharmaceuticals is owned by 84.55% institutional investors, 0.32% insiders, and 15.13% retail investors. Capital world investors is the largest institutional shareholder, holding 10.98% of VRTX shares. American Funds Growth Fund of Amer A is the top mutual fund, with 3.65% of its assets in Vertex Pharmaceuticals shares.
VRTX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Vertex Pharmaceuticals | 84.55% | 0.32% | 15.13% |
Sector | Healthcare Stocks | 57.00% | 9.27% | 33.74% |
Industry | Biotech Stocks | 68.69% | 8.88% | 22.43% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Capital world investors | 28.33M | 10.98% | $11.41B |
Vanguard group | 23.26M | 9.01% | $9.37B |
Blackrock funding, inc. /de | 21.83M | 8.46% | $8.79B |
Blackrock | 21.31M | 8.25% | $9.99B |
State street | 11.73M | 4.54% | $5.50B |
Capital research global investors | 10.43M | 4.04% | $4.20B |
Fmr | 9.22M | 3.57% | $3.71B |
Jpmorgan chase | 6.31M | 2.45% | $2.54B |
Wellington management group llp | 5.92M | 2.29% | $2.38B |
Geode capital management | 5.65M | 2.19% | $2.27B |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Kynam capital management, lp | 330.00K | 11.93% | $154.68M |
Bridger management | 41.05K | 8.88% | $16.53M |
Provident investment management | 155.07K | 5.96% | $62.45M |
Montchanin asset management | 10.74K | 4.76% | $5.03M |
Bellevue group | 487.43K | 3.78% | $196.29M |
Healthinvest partners ab | 22.26K | 3.60% | $7.60M |
Edgewood management | 2.96M | 3.42% | $1.19B |
Guoline advisory pte | 79.70K | 3.31% | $32.10M |
Birch hill investment advisors | 172.82K | 3.24% | $69.60M |
Pfm health sciences, lp | 126.99K | 3.17% | $51.14M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Norges bank | 3.41M | 0.18% | 3.41M |
Parnassus investments | 1.82M | 1.62% | 1.82M |
Capital world investors | 28.33M | 1.73% | 1.51M |
Capital research global investors | 10.43M | 0.86% | 1.43M |
Edgewood management | 2.96M | 3.42% | 1.41M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Alliancebernstein | 3.92M | 0.54% | -3.45M |
Fmr | 9.22M | 0.22% | -1.31M |
Jennison associates | 4.32M | 1.06% | -1.23M |
Blackrock | 21.31M | 0.23% | -648.44K |
Massachusetts financial services co /ma/ | 2.29M | 0.29% | -617.21K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 3.41M | 0.18% | 3.41M | $1.37B |
Parnassus investments | 1.82M | 1.62% | 1.82M | $731.28M |
Wcm investment management | 1.09M | 1.03% | 1.09M | $435.90M |
Raymond james financial | 471.91K | 0.07% | 471.91K | $190.04M |
Capital investors | 342.51K | 0.03% | 342.51K | $137.93M |
Sold Out
Holder | Change |
---|---|
Mcclarren financial advisors | -1.00 |
Mine & arao wealth creation & management, llc. | -1.00 |
Tfo-tdc | -2.00 |
Proffitt & goodson | -4.00 |
Triad wealth partners | -4.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 1,444 | -9.69% | 218,148,736 | -5.74% | 84 | 1.05% | 664 | -9.78% | 543 | -5.89% |
Sep 30, 2024 | 1,575 | -1.25% | 231,077,223 | -1.65% | 89 | 1.08% | 726 | -11.68% | 568 | 10.29% |
Jun 30, 2024 | 1,570 | 1.88% | 234,312,910 | 1.05% | 90 | 1.13% | 813 | 5.31% | 505 | -1.17% |
Mar 31, 2024 | 1,541 | 3.35% | 231,875,378 | -1.27% | 89 | 1.08% | 772 | -2.77% | 511 | 6.24% |
Dec 31, 2023 | 1,491 | 12.02% | 234,856,036 | 1.31% | 91 | 1.13% | 794 | 27.65% | 481 | 7.37% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
American Funds Growth Fund of Amer A | 9.40M | 3.65% | 1.30M |
Capital Group Growth Fnd of Amer Comp | 9.40M | 3.65% | 1.30M |
Vanguard Total Stock Mkt Idx Inv | 8.09M | 3.15% | 21.73K |
Vanguard Institutional 500 Index Trust | 7.09M | 2.76% | 118.67K |
Invesco QQQ Trust | 5.36M | 2.09% | 71.06K |
American Funds American Balanced A | 4.93M | 1.91% | -55.00K |
American Funds New Perspective A | 4.03M | 1.56% | 345.03K |
Capital Group New Perspective Comp | 4.03M | 1.56% | 345.03K |
Fidelity Contrafund | 3.25M | 1.26% | -183.00K |
SPDR® S&P 500® ETF Trust | 3.21M | 1.25% | 12.84K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 27, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | $251.93K |
Feb 27, 2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | $1.26M |
Feb 27, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | Sell | $610.56K |
Feb 25, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | $170.26K |
Feb 25, 2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | $849.84K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 15 |
2024 Q4 | - | 4 |
2024 Q3 | - | 9 |
2024 Q2 | - | 17 |
2024 Q1 | - | 30 |
VRTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools